DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Browsing by Subject
Showing results 448 to 467 of 7641
< previous
next >
- Bunak methods, morphometric indicators, jaws, anthropometric measurements. 1
- Burger’s disease, thromboangitis, vasculi tis, Raynaud’s syndrome. 1
- Burun to'sigi qiyshiqligi,odontogen gaymorit,ko'z kosasi periostiti 1
- buyrak etishmovchiligi, gemodializ, sun’iy buyrak, nefrologiya, taqsimlash, osmos. 1
- buyrak kasalligi, tubulointerstitsial o’zgarishlar, tashxis, davolash 1
- buyrak kasalliklari laborator diagnostikasi, peshob tahlili, buyrak faoliyati 2
- Buyrak-tosh kasalligi ,kosa-jom tizimi,pH,keton tanalar,bilirubin,urobilinogen 1
- Buyuk ipak yo‘li va hozirgi zamon. О‘zbekistonning turizm salohiyati va istiqbol maqsadlari 1
- Bлияние C0VID-19 на функцию яичников, женщин разного репродуктивного возраста 1
- C0VID-19, остеоартрит, semirish 1
- C0VID-19, яичники, менструально-овариальная функция. 1
- C0VID-19, яичники, менструально-овариальная функция. 1
- CANCER, TUMOR-LIKE DISEASES,LIMB BONES IN CHILDREN 1
- candidiasis, mucous membrane of an oral cavity, erythrocyte, adhesive 1
- carbon dioxide, oxygen, pollutants, light, human health, plants, breath 1
- Carcinomatosis, Intraperitoneal Chemotherapy, Hyperthermia, HIPEC, Overall And Disease-Free Survival. 1
- Cardiorenal syndrome, systemic inflammation, endothelial dysfunction, insulin resistance. 1
- cardiovascular disease, ischemic heart disease, risk factors for the development of cardiovascular disease, myocardial infarction, t-PA - tissue plasminogen activator; TAFI, thrombin-activated fibrinolytic inhibitor; TAFIa is a thrombin-activated fibrinolytic inhibitor. 1
- cardiovascular disease, ischemic heart disease, risk factors for the development of cardiovascular disease, myocardial infarction, t-PA - tissue plasminogen activator; TAFI, thrombin-activated fibrinolytic inhibitor; TAFIa is a thrombin-activated fibrinolytic inhibitor 1
- cardiovascular disease, risk factor, diabetes mellitus, arterial hypertension, atherosclerosis 1